drugset / Trial / NCT00176267

Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer

NCT00176267 ↗

Phase 2 Completed 26 enrolled Susanne Arnold Bristol-Myers Squibb · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is being performed utilizing two cycles of Paclitaxel and Carboplatin, plus low doses radiation as initial therapy prior to other treatment (surgery or radiation). The study is assessing if utilization of low doses radiation as a chemoenhancer will further increase the response rate seen with initial therapy.

Timeline

Start
2002-09
Primary completion
2005-01
Completion
2017-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule 6 unknown —
Subject Paclitaxel Small molecule 75 mg/m2 Intravenous